Evidence map›Paper›PMID 38235117›Full record

ArticleFrontiers in pharmacology2023

The protective effect of PL 1-3 on D-galactose-induced aging mice.

Pengxiao Li, Yazhong Ma, Xiaotong Wang, Xin Li, Xuekun Wang, Jie Yang, Guoyun Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Vitamin D Promotes Neuronal Survival via Nrf2 Upregulation in D-Galactose-Induced Mice: An In-Vivo and In-Silico Study.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. An Update on Neuroaging on Earth and in Spaceflight.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Involvement of SIRT1-mediated aging in liver diseases.Frontiers in cell and developmental biology · 2025
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Pengxiao LiSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng, Shandong, China.
Yazhong MaSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng, Shandong, China.
Xiaotong WangSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng, Shandong, China.
Xin LiSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng, Shandong, China.
Xuekun WangSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng, Shandong, China.
Jie YangSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng, Shandong, China.
Guoyun LiuSchool of Pharmaceutical Sciences, Liaocheng University, Liaocheng, Shandong, China.
Liaocheng University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aging population has become an issue that cannot be ignored, and research on aging is receiving increasing attention. PL

Indexed as

anti-agingapoptosisbrain agingD-galactoseinflammationoxidative stresspiperlongumine derivativePL 1-3

Identifiers

PMID38235117
PMCPMC10791853
OpenAlexW4390541140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.